-
-
-
-
-
-
-
Aytu BioScience (AYTU) Misses Q3 EPS by 53c
-
-
-
-
-
-
-
Aytu BioPharma launches EXXUA depression drug nationwide
-
-
-
-
-
-
-
Aytu Biosciences (AYTU) PT Raised to $13 at Ascendiant Capital
-
-
-
-
-
-
-
Aytu BioPharma to Present at Upcoming October 2025 Conferences
-
-
-
-
-
-
-
Aytu BioScience (AYTU) Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA
-
-
-
-
-
-
-
Aytu BioScience (AYTU) Tops Q1 EPS by 65c
-
-
-
-
-
-
-
Aytu BioPharma Disclosure Notification
-
468,192 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

